Endoglycosidases are a class of enzymes that catalyze the hydrolysis of glycosidic bonds within glycan structures, leading to the cleavage of glycan molecules at specific sites. These enzymes are commonly used in glycobiology research to modify or analyze glycan structures in proteins or other biomolecules.

The global Endoglycosidases market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Endoglycosidases Industry Forecast” looks at past sales and reviews total world Endoglycosidases sales in 2023, providing a comprehensive analysis by region and market sector of projected Endoglycosidases sales for 2024 through 2030. With Endoglycosidases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endoglycosidases industry.

This Insight Report provides a comprehensive analysis of the global Endoglycosidases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endoglycosidases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endoglycosidases market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endoglycosidases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endoglycosidases.

United States market for Endoglycosidases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Endoglycosidases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Endoglycosidases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Endoglycosidases players cover:

• CD BioGlyco
• NEB
• Ludger
• Promega
• Leadgene Biomedical

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Endoglycosidases market by product type, application, key manufacturers, and key regions and countries.

Segmentation by Type:

• Endoglycosidase F1
• Endoglycosidase F2
• Endoglycosidase F3
• Endoglycosidase H
• Others

Segmentation by Application:

• Glycan Sequencing
• Glycoprotein Production
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• CD BioGlyco
• NEB
• Ludger
• Promega
• Leadgene Biomedical
• Agilent
• Merck
• MyBiosource
• Biosynth
• Creative-Enzymes
• Rhino Bio

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Endoglycosidases market?
2. What factors are driving Endoglycosidases market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Endoglycosidases market opportunities vary by end market size?
5. How does Endoglycosidases break out by Type, by Application?